acyclovir has been researched along with Tooth-Loss* in 3 studies
1 review(s) available for acyclovir and Tooth-Loss
Article | Year |
---|---|
An unusual complication of tooth exfoliation and osteonecrosis following herpes zoster infection of trigeminal nerve: a case report and literature review.
Osteonecrosis following herpes zoster infection is a rare but severe complication, and clinicians' awareness is important for early detection and management of this condition. A case of herpes zoster of the left maxillary division of the trigeminal nerve is reported in a young female having no concurrent predisposing factors, with accompanying rare complications of alveolar bone necrosis and rapid tooth exfoliation. Acyclovir was used to manage the case effectively. The previously reported similar cases in the literature have been reviewed and the pathophysiology of tooth exfoliation and osteonecrosis by varicella zoster viruses is discussed. Topics: Acyclovir; Adult; Antiviral Agents; Cicatrix; Cranial Nerve Diseases; Facial Dermatoses; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Maxillary Diseases; Maxillary Nerve; Osteonecrosis; Tooth Loss; Virus Activation | 2013 |
2 other study(ies) available for acyclovir and Tooth-Loss
Article | Year |
---|---|
HIV-associated fulminating herpes zoster infection with alveolar necrosis and tooth exfoliation: a case report.
This paper presents a case of HIV-associated fulminating herpes zoster infection (HZI) that culminated in right mandibular necrosis and tooth exfoliation. The occurrence of such infection in immunosuppression and the impending clinical features are briefly reviewed and discussed. Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Alveolar Bone Loss; Antiviral Agents; Herpes Zoster; Humans; Male; Mandibular Diseases; Osteonecrosis; Tooth Loss | 1997 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
In patients with leukemia or lymphoma, the role of preventive oral hygiene in reducing infectious periodontal complications during aggressive chemotherapy is well documented. However, the effectiveness of these measures in preventing further dental or periodontal degradation remains to be demonstrated. 34 hospitalized patients with malignant heamatological diseases were observed. During chemotherapy, tooth brushing was replaced by 3 daily mouth-rinses with 0.2% chlorhexidine digluconate. The periodontal status of these patients, appears unchanged after 12 months. This suggests that the prophylactic measures do prevent a measurable periodontal degradation, even in the presence of pre-existing periodontal disease. Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |